Morgan Stanley’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,277
Closed -$78K 6854
2020
Q1
$78K Sell
16,277
-59,512
-79% -$285K ﹤0.01% 5294
2019
Q4
$806K Buy
75,789
+54,202
+251% +$576K ﹤0.01% 4663
2019
Q3
$225K Buy
21,587
+13,108
+155% +$137K ﹤0.01% 5073
2019
Q2
$130K Sell
8,479
-5,307
-38% -$81.4K ﹤0.01% 5201
2019
Q1
$177K Sell
13,786
-36,030
-72% -$463K ﹤0.01% 5125
2018
Q4
$473K Sell
49,816
-2,568
-5% -$24.4K ﹤0.01% 4821
2018
Q3
$870K Sell
52,384
-13,189
-20% -$219K ﹤0.01% 4646
2018
Q2
$1.05M Buy
65,573
+9,225
+16% +$148K ﹤0.01% 4606
2018
Q1
$862K Buy
56,348
+9,440
+20% +$144K ﹤0.01% 4649
2017
Q4
$732K Buy
46,908
+16,695
+55% +$261K ﹤0.01% 4755
2017
Q3
$336K Sell
30,213
-2,235
-7% -$24.9K ﹤0.01% 5101
2017
Q2
$298K Buy
32,448
+490
+2% +$4.5K ﹤0.01% 5115
2017
Q1
$274K Sell
31,958
-17,823
-36% -$153K ﹤0.01% 5166
2016
Q4
$533K Buy
49,781
+46,697
+1,514% +$500K ﹤0.01% 4896
2016
Q3
$33K Buy
3,084
+2,862
+1,289% +$30.6K ﹤0.01% 5752
2016
Q2
$2K Sell
222
-302
-58% -$2.72K ﹤0.01% 6383
2016
Q1
$2K Sell
524
-4,400
-89% -$16.8K ﹤0.01% 6425
2015
Q4
$31K Sell
4,924
-16,446
-77% -$104K ﹤0.01% 5896
2015
Q3
$189K Buy
21,370
+7,470
+54% +$66.1K ﹤0.01% 5117
2015
Q2
$164K Buy
13,900
+2,487
+22% +$29.3K ﹤0.01% 5339
2015
Q1
$165K Buy
11,413
+2,270
+25% +$32.8K ﹤0.01% 5295
2014
Q4
$156K Buy
9,143
+3,034
+50% +$51.8K ﹤0.01% 5353
2014
Q3
$76K Sell
6,109
-289
-5% -$3.6K ﹤0.01% 5580
2014
Q2
$93K Sell
6,398
-51,160
-89% -$744K ﹤0.01% 5537
2014
Q1
$1.17M Buy
57,558
+43,145
+299% +$879K ﹤0.01% 3854
2013
Q4
$282K Sell
14,413
-17,180
-54% -$336K ﹤0.01% 4847
2013
Q3
$1.43M Sell
31,593
-720
-2% -$32.6K ﹤0.01% 3493
2013
Q2
$771K Buy
+32,313
New +$771K ﹤0.01% 3931